Back
Karyopharm Therapeutics Stock Predictions
Built for Lazy Summer Markets
Get instant access today.
Sell
31
KPTI
Karyopharm Therapeutics
Last Price:
$4.50
Seasonality Move:
-6.23%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report NowKaryopharm Therapeutics Stock Forecast
-
Is Karyopharm Therapeutics Stock Undervalued?The current Karyopharm Therapeutics [KPTI] share price is $4.39. The Score for KPTI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
KPTI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics Stock Go Up Next Year?
Data Unavailable
Karyopharm Therapeutics Stock Rating
Data Unavailable
Karyopharm Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
16.95
52-Week Low:
3.51
Prediction Charts
Market Cap:
37.9M
Price in USD:
4.39
Volume:
36K
Beta:
0.81
Technical Analysis
SMA50:
5.05
SMA100:
5.72
SMA200:
8.62
52-Wk Change:
-64.66%
Stock Predictions
-
Is Karyopharm Therapeutics stock public?Yes, Karyopharm Therapeutics is a publicly traded company.
-
What is the Karyopharm Therapeutics stock quote today?The Karyopharm Therapeutics stock price is 4.39 USD today.
-
How to buy Karyopharm Therapeutics stock online?You can buy Karyopharm Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-13 | 4.22 | 4.39 | 4.53 | 4.22 |
| Jun-16 | 4.47 | 4.54 | 4.55 | 4.30 |
| Jun-17 | 4.53 | 4.37 | 4.62 | 4.32 |
| Jun-18 | 4.36 | 4.44 | 4.59 | 4.32 |
| Jun-20 | 4.56 | 4.38 | 4.56 | 4.27 |
| Jun-23 | 4.41 | 4.33 | 4.42 | 4.12 |
| Jun-24 | 4.37 | 4.65 | 4.65 | 4.30 |
| Jun-25 | 4.60 | 4.49 | 4.67 | 4.34 |
| Jun-26 | 4.56 | 4.49 | 4.56 | 4.34 |
| Jun-27 | 4.33 | 4.39 | 4.64 | 4.26 |
| Jun-30 | 4.39 | 4.31 | 4.42 | 4.25 |
| Jul-1 | 4.34 | 4.36 | 4.48 | 4.25 |
| Jul-2 | 4.37 | 4.61 | 4.85 | 4.30 |
| Jul-3 | 4.69 | 4.39 | 4.83 | 4.39 |
Karyopharm Therapeutics Earnings
Data Unavailable
Karyopharm Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $2.02 per share, an increase this year of $0.39 per share, and an increase next year of $5.80 per share.
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.